News

Quatro dos 12 medicamentos incluídos na nova norma têm indicação para o combate ao sobrepeso, razão que os popularizou como ...
The U.S. Food and Drug Administration and the pharmaceutical company Novo Nordisk are urging consumers to be on the lookout ...
Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...
As counterfeit Ozempic circulates in the U.S., the Food and Drug Administration has issued a warning to Americans. In an April 14 announcement, the FDA stated that Novo Nordisk — manufacturer of ...
will gain U.S. market share from Novo Nordisk's Ozempic and Wegovy. China’s new tariffs just reignited the same market patterns that led to triple- and quadruple-digit wins for Matt Maley.
Guggenheim’s Seamus Fernandez cut his rating on Novo Nordisk stock to Hold from Buy on Thursday, as did Evan David Seigerman ...
T he US Food and Drug Administration (FDA) and pharmaceutical company Novo Nordisk are now in an attempt to making more ...
Novo Nordisk, which produces blockbuster drugs Ozempic and Wegovy, has been in a neck-and-neck race to lead the weight-loss drug market against Mounjaro and Zepbound maker Lilly. Novo Nordisk's ...
Shares of Novo Nordisk, the Danish pharmaceutical company behind the groundbreaking GLP-1 weight loss drugs Ozempic and Wegovy, have been absolutely plummeting. The company's stock price slid over ...
The federal agency and Novo Nordisk, the Danish pharmaceutical giant that makes Ozempic, said this week that they had learned about "several hundred units" of the drug that made it onto the market ...